| Vol. 7.37 – 31 October, 2022 |
| |
|
|
| Scientists identified a novel role for RNA-binding protein LIN28a, a master regulator of cellular metabolism, in cardiac repair following injury. [Circulation] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Researchers studied the relevance of defective desmosomal adhesion for arrhythmogenic cardiomyopathy development and progression. [Circulation] |
| | Investigators found that apical neonatal mouse heart resection surgery led to rapid and consistent increases in cardiac Indoleamine 2,3 dioxygenase-1 expression and kynurenine accumulation. [Nature Communications] |
|
|
|
| Scientists generated three models of epicardial impairment in zebrafish by mutating the transcription factor genes and ablating tcf21+ epicardial cells and revealed distinct roles of the epicardium during cardiac morphogenesis and signaling pathways underlying epicardial-myocardial crosstalk. [Disease Models & Mechanisms] |
|
|
|
|
| The authors described methods for the derivation of skeletal muscle cells and their utility in skeletal muscle tissue engineering with the aim to model skeletal muscle regeneration and dystrophy in vitro. [Journal of Cachexia Sarcopenia and Muscle] |
|
|
|
| Researchers proposed hyaluronic acid-based nanoparticles as a novel encapsulation strategy to efficiently deliver pentamidine to skeletal muscle cells. In vitro studies on C2C12 myoblasts and myotubes showed an efficient nanoparticles’ internalization with minimal toxicity. [Nanomedicine-Nanotechnology Biology and Medicine] |
|
|
|
| Scientists clarified the biological and clinical significance of CXCL12 in the tumor microenvironment of oral squamous cell carcinoma by co-culturing human skeletal muscle cells. [Cancer Medicine] |
| |
|
|
| Investigators used the droplet-based scRNA-Seq method to characterize the transcriptomes of thousands of individual cells collected from the normal arteries and the arteries with ligation injury, and investigated the early responses of vascular cells and inflammatory cells to the injury. [JCI Insight] |
|
|
|
| Researchers investigated the biological functions of dexmedetomidine and its mechanisms against intracranial aneurysm formation and progression using vascular smooth muscle cells. [BMC Pharmacology and Toxicology] |
|
|
|
|
| Investigators retrospect to skeletal stem cell (SSC) identification and functional studies. They discuss the principles and approaches to identify bona fide SSCs, highlighting pioneering findings that plot the lineage atlas of SSCs. [Bone Research] |
|
|
|
| Scientists review studies published since the emergence of the COVID-19 pandemic which utilize human pluripotent stem cells and their cardiovascular derivative cell types to interrogate the tropism and effects of SARS-CoV-2 infection in the heart, as well as explore potential therapies. [Current Cardiology Reports] |
|
|
|
|
| Santhera Pharmaceuticals and ReveraGen BioPharma, Inc. announced that they have completed the rolling submission of a new drug application to the FDA, seeking priority review for vamorolone for the treatment of Duchenne muscular dystrophy. [Santhera Pharmaceuticals Holding AG] |
|
|
|
| Dyne Therapeutics, Inc. announced that the FDA has granted Fast Track designation for DYNE-251 for the treatment of Duchenne muscular dystrophy mutations amenable to exon 51 skipping. [Dyne Therapeutics, Inc.] |
|
|
|
|
| December 4 – 7, 2022 Banff, Alberta, Canada |
|
|
|
|
|
| Texas A&M University Health Science Center – Bryan, Texas, United States |
|
|
|
| Northwestern University – Chicago, Illinois, United States |
|
|
|
| AstraZeneca – Gothenburg, Sweden |
|
|
|
| University of East Anglia – Norwich, United Kingdom |
|
|
|
| University of London – Royal Veterinary College – London, United Kingdom |
|
|
|
|